annual operating expenses:
$527.21M+$158.59M(+43.02%)Summary
- As of today (May 18, 2025), CORT annual total operating expenses is $527.21 million, with the most recent change of +$158.59 million (+43.02%) on December 31, 2024.
- During the last 3 years, CORT annual operating expenses has risen by +$290.99 million (+123.18%).
- CORT annual operating expenses is now at all-time high.
Performance
CORT Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$151.40M-$2.28M(-1.48%)Summary
- As of today (May 18, 2025), CORT quarterly total operating expenses is $151.40 million, with the most recent change of -$2.28 million (-1.48%) on March 31, 2025.
- Over the past year, CORT quarterly operating expenses has increased by +$36.62 million (+31.91%).
- CORT quarterly operating expenses is now -1.48% below its all-time high of $153.67 million, reached on December 31, 2024.
Performance
CORT quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CORT Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.0% | +31.9% |
| 3 y3 years | +123.2% | +130.5% |
| 5 y5 years | +178.4% | +182.2% |
CORT Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +123.2% | -1.5% | +130.5% |
| 5 y | 5-year | at high | +178.4% | -1.5% | +190.8% |
| alltime | all time | at high | +6485.1% | -1.5% | +7651.9% |
CORT Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $151.40M(-1.5%) |
| Dec 2024 | $527.21M(+43.0%) | $153.67M(+15.5%) |
| Sep 2024 | - | $133.08M(+5.9%) |
| Jun 2024 | - | $125.68M(+9.5%) |
| Mar 2024 | - | $114.77M(+12.7%) |
| Dec 2023 | $368.61M(+29.9%) | $101.86M(+12.2%) |
| Sep 2023 | - | $90.78M(+4.9%) |
| Jun 2023 | - | $86.56M(-3.2%) |
| Mar 2023 | - | $89.42M(+13.1%) |
| Dec 2022 | $283.84M(+20.2%) | $79.08M(+15.5%) |
| Sep 2022 | - | $68.45M(-3.1%) |
| Jun 2022 | - | $70.64M(+7.6%) |
| Mar 2022 | - | $65.67M(+8.0%) |
| Dec 2021 | $236.22M(+7.3%) | $60.80M(+3.7%) |
| Sep 2021 | - | $58.62M(+0.6%) |
| Jun 2021 | - | $58.26M(-0.5%) |
| Mar 2021 | - | $58.53M(+8.4%) |
| Dec 2020 | $220.09M(+16.2%) | $53.97M(-10.6%) |
| Sep 2020 | - | $60.39M(+16.0%) |
| Jun 2020 | - | $52.07M(-3.0%) |
| Mar 2020 | - | $53.66M(+4.3%) |
| Dec 2019 | $189.38M(+21.0%) | $51.44M(+9.3%) |
| Sep 2019 | - | $47.05M(+1.7%) |
| Jun 2019 | - | $46.25M(+3.6%) |
| Mar 2019 | - | $44.63M(+10.6%) |
| Dec 2018 | $156.54M(+52.3%) | $40.35M(+0.5%) |
| Sep 2018 | - | $40.17M(-0.9%) |
| Jun 2018 | - | $40.52M(+14.2%) |
| Mar 2018 | - | $35.49M(+16.6%) |
| Dec 2017 | $102.79M(+48.8%) | $30.43M(+8.0%) |
| Sep 2017 | - | $28.16M(+28.1%) |
| Jun 2017 | - | $21.99M(-1.0%) |
| Mar 2017 | - | $22.21M(+21.8%) |
| Dec 2016 | $69.08M(+31.9%) | $18.24M(+1.4%) |
| Sep 2016 | - | $17.98M(+1.1%) |
| Jun 2016 | - | $17.79M(+18.1%) |
| Mar 2016 | - | $15.07M(+16.3%) |
| Dec 2015 | $52.37M(-1.7%) | $12.95M(+0.4%) |
| Sep 2015 | - | $12.90M(+1.7%) |
| Jun 2015 | - | $12.68M(-8.3%) |
| Mar 2015 | - | $13.83M(+16.9%) |
| Dec 2014 | $53.29M(+3.1%) | $11.83M(-2.6%) |
| Sep 2014 | - | $12.15M(-0.5%) |
| Jun 2014 | - | $12.22M(-28.5%) |
| Mar 2014 | - | $17.09M(+21.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $51.71M(+31.0%) | $14.08M(+14.2%) |
| Sep 2013 | - | $12.33M(-2.5%) |
| Jun 2013 | - | $12.65M(+0.1%) |
| Mar 2013 | - | $12.64M(+11.5%) |
| Dec 2012 | $39.49M(+22.1%) | $11.34M(+30.3%) |
| Sep 2012 | - | $8.70M(+3.4%) |
| Jun 2012 | - | $8.42M(-23.7%) |
| Mar 2012 | - | $11.03M(+11.1%) |
| Dec 2011 | $32.33M(+17.8%) | $9.93M(+54.2%) |
| Sep 2011 | - | $6.44M(-27.4%) |
| Jun 2011 | - | $8.87M(+25.0%) |
| Mar 2011 | - | $7.10M(-9.3%) |
| Dec 2010 | $27.44M(+35.3%) | $7.82M(+10.1%) |
| Sep 2010 | - | $7.11M(+10.2%) |
| Jun 2010 | - | $6.45M(+6.3%) |
| Mar 2010 | - | $6.06M(+17.5%) |
| Dec 2009 | $20.28M(+1.9%) | $5.16M(+10.6%) |
| Sep 2009 | - | $4.67M(-4.5%) |
| Jun 2009 | - | $4.89M(-12.1%) |
| Mar 2009 | - | $5.56M(-9.8%) |
| Dec 2008 | $19.90M(+56.3%) | $6.16M(+24.0%) |
| Sep 2008 | - | $4.97M(+6.0%) |
| Jun 2008 | - | $4.69M(+14.8%) |
| Mar 2008 | - | $4.08M(-7.6%) |
| Dec 2007 | $12.73M(-50.8%) | $4.42M(+22.1%) |
| Sep 2007 | - | $3.62M(+85.3%) |
| Jun 2007 | - | $1.95M(-28.6%) |
| Mar 2007 | - | $2.74M(-32.7%) |
| Dec 2006 | $25.88M(+22.3%) | $4.06M(-37.9%) |
| Sep 2006 | - | $6.55M(-19.8%) |
| Jun 2006 | - | $8.16M(+15.0%) |
| Mar 2006 | - | $7.10M(+29.0%) |
| Dec 2005 | $21.16M(+31.9%) | $5.50M(+0.4%) |
| Sep 2005 | - | $5.48M(+25.0%) |
| Jun 2005 | - | $4.39M(-24.2%) |
| Mar 2005 | - | $5.79M(+4.8%) |
| Dec 2004 | $16.05M(+60.9%) | $5.52M(+29.7%) |
| Sep 2004 | - | $4.26M(+15.3%) |
| Jun 2004 | - | $3.69M(+43.8%) |
| Mar 2004 | - | $2.57M(+27.3%) |
| Dec 2003 | $9.97M(-47.0%) | $2.02M(-6.7%) |
| Sep 2003 | - | $2.16M(-26.0%) |
| Jun 2003 | - | $2.92M(+2.0%) |
| Mar 2003 | - | $2.87M |
| Dec 2002 | $18.80M(+134.8%) | - |
| Dec 2001 | $8.01M | - |
FAQ
- What is Corcept Therapeutics Incorporated annual total operating expenses?
- What is the all time high annual operating expenses for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual operating expenses year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly operating expenses year-on-year change?
What is Corcept Therapeutics Incorporated annual total operating expenses?
The current annual operating expenses of CORT is $527.21M
What is the all time high annual operating expenses for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual total operating expenses is $527.21M
What is Corcept Therapeutics Incorporated annual operating expenses year-on-year change?
Over the past year, CORT annual total operating expenses has changed by +$158.59M (+43.02%)
What is Corcept Therapeutics Incorporated quarterly total operating expenses?
The current quarterly operating expenses of CORT is $151.40M
What is the all time high quarterly operating expenses for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly total operating expenses is $153.67M
What is Corcept Therapeutics Incorporated quarterly operating expenses year-on-year change?
Over the past year, CORT quarterly total operating expenses has changed by +$36.62M (+31.91%)